{"title":"对 \"通过抑制 NLRP3 炎症小体激活 NR1H3 减轻脓毒症心肌损伤的严重程度 \"的更正","authors":"","doi":"10.1002/btm2.10707","DOIUrl":null,"url":null,"abstract":"<p>\n <span>Chao Deng</span>, <span>Qiong Liu</span>, <span>Huadong Zhao, Lu</span> <span>Qian, Wagnrui Lei</span>, <span>Wenwen Yang</span>, <span>Zhenxing Liang</span>, <span>Ye Tian</span>, <span>Shaofei Zhang</span>, <span>Changyu Wang</span>, <span>Ying Chen</span>, <span>Yang Yang</span>. <span>Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome</span>. <i>Bioeng Transl Med</i>. <span>2023</span>; <span>8</span>(<span>3</span>):e10517.</p><p>An inaccuracy has been found in the statistical graph of ABCA1 in Figure 2c of the published article. The corrected version of Figure 2 is shown below.</p><p>We apologize for this error.</p>","PeriodicalId":9263,"journal":{"name":"Bioengineering & Translational Medicine","volume":"9 6","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/btm2.10707","citationCount":"0","resultStr":"{\"title\":\"Correction to “Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome”\",\"authors\":\"\",\"doi\":\"10.1002/btm2.10707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>\\n <span>Chao Deng</span>, <span>Qiong Liu</span>, <span>Huadong Zhao, Lu</span> <span>Qian, Wagnrui Lei</span>, <span>Wenwen Yang</span>, <span>Zhenxing Liang</span>, <span>Ye Tian</span>, <span>Shaofei Zhang</span>, <span>Changyu Wang</span>, <span>Ying Chen</span>, <span>Yang Yang</span>. <span>Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome</span>. <i>Bioeng Transl Med</i>. <span>2023</span>; <span>8</span>(<span>3</span>):e10517.</p><p>An inaccuracy has been found in the statistical graph of ABCA1 in Figure 2c of the published article. The corrected version of Figure 2 is shown below.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":9263,\"journal\":{\"name\":\"Bioengineering & Translational Medicine\",\"volume\":\"9 6\",\"pages\":\"\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/btm2.10707\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering & Translational Medicine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/btm2.10707\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering & Translational Medicine","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/btm2.10707","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Correction to “Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome”
Chao Deng, Qiong Liu, Huadong Zhao, LuQian, Wagnrui Lei, Wenwen Yang, Zhenxing Liang, Ye Tian, Shaofei Zhang, Changyu Wang, Ying Chen, Yang Yang. Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome. Bioeng Transl Med. 2023; 8(3):e10517.
An inaccuracy has been found in the statistical graph of ABCA1 in Figure 2c of the published article. The corrected version of Figure 2 is shown below.
期刊介绍：
Bioengineering & Translational Medicine, an official, peer-reviewed online open-access journal of the American Institute of Chemical Engineers (AIChE) and the Society for Biological Engineering (SBE), focuses on how chemical and biological engineering approaches drive innovative technologies and solutions that impact clinical practice and commercial healthcare products.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
